©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Expression of Phosphatidylethanolamine N-Methyltransferase-2 Is Markedly Enhanced in Long Term Choline-deficient Rats (*)

(Received for publication, August 4, 1995; and in revised form, November 13, 1995)

Zheng Cui Dennis E. Vance (§)

From the Lipid and Lipoprotein Research Group and Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2S2, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

When rats are fed a choline-deficient (CD) diet, acute fatty liver develops along with other biochemical changes. However, when choline deficiency is prolonged, the growth rate of CD rats is similar to that of control rats fed a choline-supplemented diet. Furthermore, CD rats maintain their levels of choline-containing lipids, such as phosphatidylcholine, lysophosphatidylcholine, and sphingomyelin. The mechanism for this compensation in CD rats was investigated. We screened the major tissues for the activities of two important enzymes involved in the biosynthesis of phosphatidylcholine, CTP:phosphocholine cytidylyltransferase (CT) and phosphatidylethanolamine N-methyltransferase (PEMT). Only the livers of CD rats had higher specific enzyme activities of PEMT and CT than control animals. The amount of PEMT2, one of two PEMTs in liver, increased 5-fold in CD rats after 6 weeks on the CD diet. A similar increase in the level of PEMT2 mRNA suggested that this activation was due to enhanced expression of the PEMT2 gene in CD livers. The labeling of phosphatidycholine in isolated hepatocytes from CD rats was consistent with the conversion of PE to PC being increased as a result of a higher expression of liver PEMT. We conclude that activation of PE methylation at the level of gene expression may be the mechanism by which CD rats compensate for the lack of dietary choline.


INTRODUCTION

The CDP-choline pathway for PC (^1)biosynthesis is the major route for choline utilization in all eucaryotic cells. Moreover, the CDP-choline pathway is apparently vital for all mammalian cells (Eagle, 1955). A temperature-sensitive mutation in CT of the CDP-choline pathway of CHO cells leads to cell death at the restrictive temperature (Esko et al., 1981). The rate of PC synthesis is usually regulated at the second step of the pathway catalyzed by CT (Vance and Choy, 1979). CT can be regulated either by translocation of a soluble inactive form to an active membrane-bound enzyme (Vance, 1990a) or by gene expression (Tessner et al., 1991; Houweling et al., 1993).

In animals, choline is provided from either diet or endogenous synthesis. A normal diet contains enough choline to satisfy the normal growth of animals (Zeisel, 1981; Zeisel and Blusztajn, 1994). Choline and phosphocholine molecules are also generated endogenously from degradation of PC or other choline-containing lipids by phospholipases C and D. However, phospholipases C and D are part of a recycling pathway, and choline is not generated de novo. The only known endogenous pathway that synthesizes choline molecules with significant capacity is the PEMT pathway in animal liver (Vance and Ridgway, 1988). Methylation of phosphoethanolamine has been shown to occur in some tissues, but at a much lower level than the PEMT pathway in liver (Andriamampandry et al. 1989, 1992). Although tissues other than liver have measurable PEMT activity, these activities are less than a few percent of the activity in liver and are considered to be quantitatively insignificant.

At least two PEMTs that are immunologically distinct are present in rat liver (Cui et al., 1993). PEMT1 is apparently located on the endoplasmic reticulum, whereas PEMT2 is exclusively associated with a unique liver membrane fraction, the mitochondria-associated membrane (Vance, 1990b; Cui et al., 1993). The cDNA for PEMT2 was cloned from a rat liver library and expressed in several cell types (Cui et al., 1993). The expressed PEMT2 catalyzes all three steps of PE methylation.

It is clear that dietary choline plays a critical role in animals (Zeisel, 1981; Zeisel and Blusztajn, 1994). However, it is not known if dietary choline and endogenously made choline have the same physiological roles. Nor is the contribution known for endogenous and exogenous choline to the total choline pool in animals. In the last few decades, the physiological role of dietary choline has been investigated in several animal models fed a CD diet and in animal cells cultured in CD media (for reviews, see Zeisel(1981) and Zeisel and Blusztajn(1994)). Deprivation of choline from the diet results in serious physiological changes. The rapid accumulation of triacylglycerol in the liver is the most pronounced among other changes in CD rats (Lombardi, 1971). Accumulation of diacylglycerol (Blusztajn and Zeisel, 1989) and activation of protein kinase C (da Costa et al., 1993) were also observed in CD rat livers. These biochemical changes are believed to be factors contributing to a higher incidence of hepatocarcinoma in CD rats in the absence of any known carcinogens (Chandar and Lombardi, 1988).

We were interested in the mechanism by which CD rats compensate for the loss of dietary choline. We hypothesized that the liver PE methylation pathway would be activated in rats fed a CD diet for more than 2 weeks so that more PC would be synthesized which subsequently would be a source of endogenous choline. The results show that CD rats used choline from an endogenous source to compensate for the loss of dietary choline. After 3 weeks on a CD diet, there was a gradual increase of PEMT2 protein (approximately 5-fold after 12 weeks) with a concomitant increase in PEMT2 mRNA. We postulate that the activation of the PEMT pathway as a source for endogenous choline may be responsible for the normal body weight gain and normal content of choline-containing lipids in CD rats.


EXPERIMENTAL PROCEDURES

Materials

All chemicals were purchased from Sigma unless noted otherwise. Radioactive isotopes and ECL detection kits for immunoblots were obtained from Amersham Corp. BCA protein assay kits were from Pierce Chemicals.

Animals and Care

Three-week-old male Sprague-Dawley rats, with an average weight of 40 g, were used to start the desired diets. The CD diet was purchased from ICN, and 0.4% choline chloride was added for the control diet (CS). Rats were provided with normal 12-h light-dark cycle and free access to the diets and drinking water.

Preparation of Protein Samples of Rat Tissues

The circulatory system was perfused with phosphate-buffered saline until the perfusates were clear. Tissues were dissected and rinsed with ice-cold phosphate-buffered saline. Tissues were cut into small pieces and homogenized in a Polytron homogenizer for 2 times 15 s in homogenization buffer (10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride). The homogenates were centrifuged for 5 min at 600 times g. The supernatants were collected and used as total cellular protein samples.

Immunoblots

The proteins of total liver homogenates from CD and CS rats were separated on SDS-polyacrylamide (12.5%) gels containing 0.1% SDS and transferred to nitrocellulose membranes (Laemmli, 1970; Towbin et al., 1979). The blots were probed with antibodies and immunoreactive material was detected by the ECL system. Rabbit anti-rat protein disulfide isomerase polyclonal antiserum (1:3000 dilution) and the cDNA for this enzyme were a gift from Dr. M. Michalak (University of Alberta). The rabbit anti-rat liver PEMT2 antibody was described earlier (Cui et al., 1993).

Labeling of Lipids and Metabolites

Hepatocytes were isolated (Davis et al., 1979) and the cell plating density was 3 times 10^6/dish (28 cm^2). The labeled precursors were: [^3H]ethanolamine, 5 µCi/dish; [methyl-^3H]methionine, 30 µCi/dish, and [methyl-^3H]choline, 30 µCi/dish. The cells were plated for 4 h in Dulbecco's modified Eagle's medium that contained 17% fetal bovine serum ± 28 µM choline. The cells were subsequently pulsed with various labeled precursors for 8 h in the same medium. The cells were harvested, total lipids extracted (Folch et al., 1957), and phospholipids were separated on silica gel G thin-layer chromatography plates. The solvent system used was chloroform/methanol/acetic acid/formic acid/water at the ratio of 299/128/51/17/4.3 (v/v). The PC and PE bands were visualized by exposure to iodine vapor and extracted for measurement of radioactivity and phosphorus (Rouser et al., 1966). Phosphatidylcholine head groups were analyzed essentially as described by Kuksis et al.(1981).

Enzyme Assays

CT assays were done according to Weinhold et al.(1986) with modifications (Yao et al., 1990). Phosphatidylethanolamine N-methyltransferase assays have been described (Ridgway and Vance, 1992). Phosphatidylmonomethylethanolamine was used as an exogenous substrate.

mRNA Isolation and Analysis

Total liver mRNAs were isolated from liver using a Quickprep kit from Pharmacia Biotech Inc. according to the manufacturer's instruction. The procedure used for Northern blotting has been described previously (Reed and Mann, 1985). Two µg of mRNA were loaded in each lane of a 1% agarose gel. Capillary blotting was used to transfer RNA from the gel to the membrane. Full-length cDNAs of PEMT2 and protein disulfide isomerase were labeled with P by a random primer labeling kit from Life Technologies, Inc.. Hybridizations were done at 42 °C in the presence of 50% formamide. The stringency condition of final washes was 65 °C and 0.2 times sodium chloride, sodium citrate solution. The blot was exposed to x-ray film overnight.


RESULTS

Normal Weight Gain and Phospholipid Composition in Long Term Choline-deficient Rats

CD rats had similar growth rates to control rats. Body weights of both CD and CS rats increased over 13-fold from 40 g at the beginning of the diet to 550 g after 12 weeks on the diets (Fig. 1). CD rats had slightly enlarged, fatty livers with yellow-brown color throughout the 12-week period. No other visible changes were detected in these rats.


Figure 1: Increase in weight of choline-deficient (CD) and choline-supplemented (CS) rats. Three-week-old male Sprague-Dawley rats, with an average weight of 40 g, were fed either a CD diet or CD diet supplemented with 0.4% choline chloride. Rats were provided with normal 12-h light-dark cycle and free access to the diets and drinking water. Each point is the average ± S.D. for at least three animals. In some cases the error bars are to small to be seen.



Since dietary choline is considered an important source for the CDP-choline pathway of PC synthesis (Zeisel, 1981), we were curious if withdrawal of choline from the diet would result in any significant change in phospholipids. No significant differences in the amounts of PE, phosphatidylserine, phosphatidylinositol, lyso-PC, and sphingomyelin were found in CD compared with CS rats during 12 weeks on the diet (data not shown). Fig. 2shows that the levels of PC in the major tissues of rats were similar during 12 weeks on CD and CS diets. Since the CD rats receive no choline in their diets, it would be impossible for these rats to maintain normal levels of PC without endogenous synthesis of choline. Since PE methylation is the only known pathway with significant capacity for synthesis of new choline molecules in the form of PC, we speculated that this pathway was activated in CD rats to maintain a normal body weight gain and unchanged levels of choline-containing lipids.


Figure 2: The concentration of PC in the major tissues of choline-deficient (CD) and choline supplemented (CS) rats after 3, 6, or 12 weeks. The values represent the means ± S.D. for three or more animals.



Activation of Hepatic CT and PEMT in CD Rats

All major tissues of CD and CS rats were screened for CT and PEMT activities so that we could determine which tissue(s) might be responsible for this increased endogenous synthesis of choline. No significant change of CT or PEMT activities was detected in any tissue except liver (Fig. 3Fig. 4Fig. 5). The specific activity of CT increased approximately 90% in the livers of rats fed the CD diet for 3 weeks (Fig. 3) and remained elevated through 12 weeks on the diet. Since CT was assayed at optimal concentrations of activating phospholipids (Yao et al., 1990), the increased CT activity might have been due to more CT protein.


Figure 3: The activity of CTP:phosphocholine cytidylyltransferase (CT) in tissues of choline-deficient (CD) and choline supplemented (CS) rats after 3, 6, or 12 weeks on the diet. Homogenates were prepared from CD and CS rats at the indicated times on the diet. Twenty-five µg of total cellular protein were assayed for CT activity. Each point represents the mean ± S.D. for three animals.




Figure 4: Redistribution of hepatic CTP:phosphocholine cytidylyltransferase (CT) activity from soluble to membrane fractions in choline-deficient (CD) and choline supplemented (CS) rats. Supernatant and membrane fractions were isolated by centrifugation of liver homogenates at 350,000 times g for 15 min. Each point represents the mean ± S.D. for three rats.




Figure 5: Phosphatidylethanolamine N-methyltransferase (PEMT) activity in tissues of choline-deficient (CD) and choline-supplemented (CS) rats. Homogenates from various tissues were prepared and 25 µg of total cellular protein were assayed for PEMT activity. The PEMT activity recovered from heart, spleen, kidney, skeletal muscle, pancreas, and intestine were all lower in activity than brain which has less than 2% of the PEMT activity recovered from normal liver. The results are expressed as mean ± S.D. for three animals.



Since an important mechanism for regulating CT activity is the translocation of the enzyme between soluble and particulate fractions, we measured the specific activity of CT. CT activities in CD compared with CS rat livers increased in particulate fractions and decreased in soluble fractions during the first 6 weeks (Fig. 4). After 12 weeks, the distribution of CT returned to values similar to those obtained from CS rat livers.

The liver PEMT activity was increased throughout the study period in CD compared with CS rats (Fig. 5). This increase of hepatic PEMT activity suggested that liver may be primarily responsible for the synthesis of endogenous choline required in the CD rats. Since no specific antibody was available for PEMT1, we were unable to identify any possible change in this protein. However, the amount of PEMT2 protein in the livers of CD rats was almost 5 times that from CS rats after 12 weeks on the diet (Fig. 6). The equal loading of liver proteins was confirmed by probing the same blots with a specific antibody to protein disulfide isomerase which was present equally in all samples. The total cellular protein profiles of homogenates from CD and CS livers were also identical when examined by SDS-polyacrylamide gel electrophoresis (data not shown).


Figure 6: Immunoblots of liver homogenates from choline-deficient (CD) and choline-supplemented (CS) rats after 3, 6, and 12 weeks on the diet. Twenty-five µg of protein from liver homogenates were separated on 12.5% polyacrylamide gels that contained 0.1% SDS. The proteins were transferred to nitrocellulose paper and probed with polyclonal antibodies PEMT2 (top panel) and protein disulfide isomerase (PDI) (bottom panel). This experiment was repeated three times with similar results.



PEMT2 mRNA Was Also Increased in Choline-deficient Rat Livers

We analyzed the PEMT2 mRNA of CD and CS rat livers by Northern blotting experiments with the cDNA probe for PEMT2. The total mRNAs were normalized to equal levels of protein disulfide isomerase mRNA. The increases of PEMT2 mRNA were very similar to the changes of the PEMT2 protein in CD rat livers. There was a gradual increase of the PEMT2 mRNA from 3 to 12 weeks on CD diet (Fig. 7). This result suggested that the enhanced expression of the PEMT2 gene was responsible for the increased PEMT2 protein.


Figure 7: Elevated levels of liver phosphatidylethanolamine N-methyltransferase-2 (PEMT2) mRNA in choline-deficient (CD) compared with choline-supplemented (CS) rats. Two µg of total liver mRNAs were separated on a 1% agarose gel under denaturing conditions. The mRNAs were transferred to nylon membranes and probed with P-labeled cDNA probes for PEMT2 (top panel) and protein disulfide isomerase (PDI) (bottom panel). This experiment was repeated twice with similar results.



Increased Incorporation of Radioactivity into PC in CD Rat Hepatocytes

Hepatocytes were isolated from CD and CS rats and incubated with radioactive precursors of PC synthesis. When [methyl-^3H]methionine was used, over 95% of the label in lipid was incorporated into PC and 5% was in lyso-PC and sphingomyelin. At the 3-week time point, labeling of PC by [methyl-^3H]methionine was more than 2-fold higher in CD than in CS hepatocytes (Fig. 8). This increase was essentially sustained up to 12 weeks. The labeling of PC from [methyl-^3H]methionine in CS hepatocytes was unchanged throughout the dietary period. These data are in agreement with the increased activity of PEMT in livers of rats fed the CD diet. Enhanced conversion of PE to PC was confirmed by [^3H]ethanolamine labeling experiments (Fig. 8).


Figure 8: Incorporation of radioactive precursors into phosphatidylcholine (PC) in isolated hepatocytes from choline-deficient (CD) and choline-supplemented (CS) rats. The cell plating density was 3 times 10^6/dish (28 cm^2). The labeled precursors used were: [^3H]ethanolamine, 5 µCi/dish; [methyl-^3H]methionine, 30 µCi/dish; and [methyl-^3H]choline, 30 µCi/dish. The cells were plated for 4 h in Dulbecco's modified Eagle's medium and then pulsed with one of the labeled precursors for 8 h. The cells were harvested and PC isolated. The results are expressed as the mean ± S.D. from three experiments.



PC can be specifically labeled by [^3H-methyl]choline via the CDP-choline pathway. As shown in Fig. 8, there was over a 2.5-fold increase of PC labeling by [methyl-^3H]choline in CD hepatocytes at the 3-week time point. This increase was reduced at week 6 and further diminished at week 12.

When cells are labeled with radioactive substrates, the pool size of the precursor substrates in the cells influences the incorporation of radioactivity. We considered that the pool size of choline or phosphocholine in the isolated hepatocytes might be smaller from CD, compared with CS, rats, thus resulting in increased incorporation of label, even though the rate of PC biosynthesis might not be enhanced. To address this concern, we preincubated hepatocytes from CD and CS rats with 200 µM of choline for 4 h before labeling with [methyl-^3H]choline. The labeling pattern of PC in both CD and CS hepatocytes was very similar to that obtained without preincubation with choline (data not shown). This result suggested that the increased incorporation of [methyl-^3H]choline into PC in CD hepatocytes was not due to a smaller pool size of choline. Moreover, the data are also consistent with activation of CT, the rate-limiting enzyme, in the livers of CD rats ( Fig. 3and Fig. 4). The labeling studies with [^3H]methionine and [^3H]ethanolamine are subject to the same reservations about pool sizes of precursors. However, since both precursors gave similar results (enhanced conversion of PE to PC), it is unlikely that the increased labeling was due to a pool size effect.


DISCUSSION

The major conclusion is that the PE methylation pathway and PEMT2 in liver are activated in rats fed a CD diet for up to 12 weeks. The activation of PEMT2 was achieved largely at the level of enhanced gene expression. The activated pathway was able to synthesize more endogenous choline in the form of PC. This is the first demonstration of an enhanced expression of PEMT2 at the level of the gene. Moreover, to our knowledge, the 5-fold increase of PEMT2 protein in the livers from CD rats is the most significant in vivo activation observed for an enzyme involved in PC biosynthesis in animals. The striking activation of PEMT2 at the level of gene expression in CD rats suggests that PE methylation might play a crucial role in maintenance of normal growth of CD rats.

Earlier studies in which rats were fed a CD diet for only 3 days showed no significant change of PEMT protein as monitored with a polyclonal antibody against purified rat liver PEMT (Ridgway et al., 1989). However, there was a 2-fold increase in PEMT activity in the endoplasmic reticulum fractions from CD compared with CS rat livers. Thus, although there is a doubling of PEMT activity in the livers from CD rats within 3 days after the CD diet is initiated, the increase of PEMT2 protein only occurs after 3 weeks of choline deprivation. Since no specific antibody against PEMT1 is available, we do not know if PEMT1 were activated during long term choline deficiency.

We have recently published evidence that the PE methylation pathway can be functionally different from the CDP-choline pathway (Houweling et al., 1995). When the cDNA for PEMT2 was transfected into mutant CHO cells with a temperature-sensitive defect in CT, PC generated from PE did not satisfy the functional role of the CDP-choline pathway. In CD rats, it appears that PC newly synthesized from the PE methylation pathway does compensate for decreased supply of dietary choline. The results from CHO cells and CD rats are not contradictory since choline or phosphocholine, generated by phospholipase D and C, respectively, could be utilized by the CDP-choline pathway in CD rats but not in the mutant CHO cells that lack CT.

The activation of the CDP-choline pathway in long term choline deficiency extends our previous observations that CT activity is elevated during several days of choline deficiency (Ridgway et al., 1989). We speculate that once dietary choline is withdrawn, rats not only have to synthesize extra endogenous choline, but would also have to use the available choline molecules more efficiently. Activation of CT ensures the conversion of choline to PC at a maximal rate. Under these conditions the supply of substrate, rather than CT activity, would become limiting.

Liver is the only organ which has a significant level of PEMT activity (Vance and Ridgway, 1988) and PEMT2 is also exclusively localized to liver (Cui et al., 1993). We postulate that the liver synthesizes choline-containing lipids which are secreted as lyso-PC or as a component of very low density lipoproteins and transported to other organs which have low PEMT activities. Since the activity for PEMT in non-hepatic tissues is very low and was not enhanced in CD rats, it seems unlikely that significant PE was converted to PC in these tissues. It is also possible that non-hepatic tissues are able to synthesize choline from other pathways. Andriamampandry et al.(1989, 1992) reported that brain and other tissues contain a methyltransferase activities which convert phosphoethanolamine to phosphocholine, although the activities are relatively low.

Even though PE, PC, and other choline-containing lipids are maintained at a relatively normal level in CD rats, the effects of choline deficiency are not totally compensated. The accumulation of triacylglycerol, diacylglycerol, and the activation of protein kinase C still occur (Zeisel and Blusztajn, 1994). The reason for this is not clear.

PEMT2 has been implicated in the growth control of liver and suppression of hepatocarcinogenesis (Cui et al., 1994). On the other hand, choline deficiency for very long periods such as one year makes rats much more susceptible to cancer (Lombardi, 1971). Does PEMT2 have a role in liver carcinogenesis induced by choline deficiency? During choline deficiency enhanced PEMT expression could very well be essential for animal survival. If this dietary condition were prolonged for over 50 weeks, the activated PEMT pathway may fail to be sustained in some hepatocytes by either mutation or other mechanisms. Since the absence of PEMT2 is associated with liver tumors and PEMT2 expression is inhibitory for hepatoma cell growth (Cui et al., 1994), loss of PEMT2 may induce the development of liver cancer. If we were able to obtain mice in which the PEMT2 gene has been disrupted, it would be interesting to see if such mice were more susceptible to liver carcinoma.


FOOTNOTES

*
This work was supported by grants from the Heart and Stroke Foundation of Alberta and the Medical Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Medical Scientist of the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed. Fax: 403-492-3383; :dvance{at}gpu.srv.ualberta.ca.

(^1)
The abbreviations used are: PC, phosphatidylcholine; PE, phosphatidylethanolamine; CT, CTP:phosphocholine cytidylyltransferase; PEMT, phosphatidylethanolamine N-methyltransferase; CD, choline-deficient; CS, choline-supplemented.


ACKNOWLEDGEMENTS

We are very grateful to Sandra Ungarian and Bosco Lo for excellent technical assistance and to Drs. Jean Vance and Martin Houweling for helpful suggestions.


REFERENCES

  1. Andriamampandry, C., Freysz, L., Kanfer, J. N., Dreyfus, H., and Massarelli, R. (1989) Biochem. J. 264, 555-562 [Medline] [Order article via Infotrieve]
  2. Andriamampandry, C., Massarrelli, R., and Kanfer, J. N. (1992) Biochem. J. 288, 267-272 [Medline] [Order article via Infotrieve]
  3. Blusztajn, J. K., and Zeisel, S. H. (1989) FEBS Lett. 243, 267-270 [CrossRef][Medline] [Order article via Infotrieve]
  4. Chandar, N., and Lombardi, N. (1988) Carcinogenesis 9, 259-263 [Abstract]
  5. Cui, Z., Vance, J. E., Chen, M. H., Voelker, D. R., and Vance, D. E. (1993) J. Biol. Chem. 268, 16655-16663 [Abstract/Free Full Text]
  6. Cui, Z., Houweling, M., and Vance, D. E. (1994) J. Biol. Chem. 269, 24531-24533 [Abstract/Free Full Text]
  7. da Costa, K., Cochary. E. F., Blusztajn, J. K., Garner, S. C., and Zeisel, S. H. (1993) J. Biol. Chem. 268, 2100-2105 [Abstract/Free Full Text]
  8. Davis, R. A., Engelhorn, S. C., Pangburn, S. H., Weinstein, D. B., and Steinberg, D. (1979) J. Biol. Chem. 254, 2010-2016 [Medline] [Order article via Infotrieve]
  9. Eagle, H. (1955) J. Exp. Med. 102, 595-600
  10. Esko, J. D., Wermuth, M. M., and Raetz, C. R. H. (1981) J. Biol. Chem. 256, 7388-7393 [Free Full Text]
  11. Folch, J., Lees, M., and Sloane-Stanley, G. H. (1957) J. Biol. Chem. 226, 497-509 [Free Full Text]
  12. Houweling, M., Tijburg, L. B. M., Vaartjes, W. J., Kalmar, G. B., Cornell, R. B., and van Golde, L. M. G. (1993) Eur. J. Biochem. 214, 927-933 [Abstract]
  13. Houweling, M., Cui, Z., and Vance, D. E. (1995) J. Biol. Chem. 270, 16277-16282 [Abstract/Free Full Text]
  14. Kuksis, A., Myher, J. J., and Geher, K. (1981) J. Chromatogr. 224, 1-23 [Medline] [Order article via Infotrieve]
  15. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  16. Lombardi, B. (1971) Fed. Proc. 30, 139-142 [Medline] [Order article via Infotrieve]
  17. Reed, K. C., and Mann, D. A. (1985) Nucleic Acids Res. 13, 7207-7221 [Abstract]
  18. Ridgway, N. D., and Vance, D. E. (1992) Methods Enzymol. 209, 366-374 [Medline] [Order article via Infotrieve]
  19. Ridgway, N. D., Yao, Z., and Vance, D. E. (1989) J. Biol. Chem. 264, 1203-1207 [Abstract/Free Full Text]
  20. Rouser, G., Siakoto, A. M., and Fleischer, D. (1966) Lipids 1, 85-86
  21. Sundler, A., and Åkesson, B. (1975) J. Biol. Chem. 250, 3359-3367 [Abstract]
  22. Tessner, T. G., Rock, C. O., Kalmar, G. B., Cornell, R. B., and Jackowski, S. (1991) J. Biol. Chem. 266, 16261-16264 [Abstract/Free Full Text]
  23. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  24. Vance, D. E. (1990a) Biochem. Cell Biol. 68, 1151-1165 [Medline] [Order article via Infotrieve]
  25. Vance, J. E. (1990b) J. Biol. Chem. 265, 7248-7256 [Abstract/Free Full Text]
  26. Vance, D. E., and Choy, P. C. (1979) Trends Biochem. Sci. 4, 145-148
  27. Vance, D. E., and Ridgway, N. D. (1988) Prog. Lipid. Res. 27, 61-79 [CrossRef][Medline] [Order article via Infotrieve]
  28. Weinhold, P. A., Rounsifer, M. E., and Feldman, D. A. (1986) J. Biol. Chem. 261, 5104-5110 [Abstract/Free Full Text]
  29. Yao, Z., Jamil, H., and Vance, D. E. (1990) J. Biol. Chem. 265, 4326-4331 [Abstract/Free Full Text]
  30. Zeisel, S. H. (1981) Annu. Rev. Nutr. 1, 95-121 [Medline] [Order article via Infotrieve]
  31. Zeisel, S. H., and Blusztajn, J. K. (1994) Annu. Rev. Nutr. 14, 269-296 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.